BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population
出版年份 2018 全文链接
标题
BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population
作者
关键词
-
出版物
PLoS One
Volume 13, Issue 10, Pages e0204768
出版商
Public Library of Science (PLoS)
发表日期
2018-10-05
DOI
10.1371/journal.pone.0204768
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Erratum: Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
- (2017) Yufei Wang et al. NATURE GENETICS
- The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
- (2016) Javaid Iqbal et al. BRITISH JOURNAL OF CANCER
- The role of germline alterations in the DNA damage response genesBRIP1andBRCA2in melanoma susceptibility
- (2016) Rainer Tuominen et al. GENES CHROMOSOMES & CANCER
- Familial Risk and Heritability of Cancer Among Twins in Nordic Countries
- (2016) Lorelei A. Mucci et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Variants Fok1 and Bsm1 on VDR are associated with the melanoma risk: evidence from the published epidemiological studies
- (2015) Wei Hou et al. BMC GENETICS
- Skin cancer risk inBRCA1/2mutation carriers
- (2015) P.V. Gumaste et al. BRITISH JOURNAL OF DERMATOLOGY
- Genetic Variants in Fanconi Anemia Pathway Genes BRCA2 and FANCA Predict Melanoma Survival
- (2015) Jieyun Yin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Melanoma genetics
- (2015) Jazlyn Read et al. JOURNAL OF MEDICAL GENETICS
- Cancers associated withBRCA1andBRCA2mutations other than breast and ovarian
- (2014) Jacqueline Mersch et al. CANCER
- Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
- (2014) Jianxin Shi et al. NATURE GENETICS
- Detailed comparison of two popular variant calling packages for exome and targeted exon studies
- (2014) Charles D. Warden et al. PeerJ
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk
- (2013) Kyriaki Michailidou et al. NATURE GENETICS
- Predicting the Functional Effect of Amino Acid Substitutions and Indels
- (2012) Yongwook Choi et al. PLoS One
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
- (2011) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
- (2011) A. Moran et al. Familial Cancer
- A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
- (2011) Corine Bertolotto et al. NATURE
- Predicting the functional impact of protein mutations: application to cancer genomics
- (2011) Boris Reva et al. NUCLEIC ACIDS RESEARCH
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
- (2009) Prateek Kumar et al. Nature Protocols
- Absence of founder BRCA1 and BRCA2 mutations in coetaneous malignant melanoma patients of Ashkenazi origin
- (2008) Luna Kadouri et al. Familial Cancer
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results
- (2008) Sharon E. Plon et al. HUMAN MUTATION
- Common variants of DNA repair genes and malignant melanoma
- (2007) T. Dębniak et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started